Page last updated: 2024-10-30

losartan and Eclampsia

losartan has been researched along with Eclampsia in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Eclampsia: Onset of HYPERREFLEXIA; SEIZURES; or COMA in a previously diagnosed pre-eclamptic patient (PRE-ECLAMPSIA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Novotny, SR1
Wallace, K1
Heath, J1
Moseley, J1
Dhillon, P1
Weimer, A1
Wallukat, G1
Herse, F1
Wenzel, K1
Martin, JN1
Dechend, R1
Lamarca, B1

Other Studies

1 other study available for losartan and Eclampsia

ArticleYear
Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2012, May-15, Volume: 302, Issue:10

    Topics: Adoptive Transfer; Angiotensin II Type 1 Receptor Blockers; Animals; Autoantibodies; Blood Pressure;

2012